Andre Tapp, MD

Recent Publications

Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.
(2017 Jul 11)
JAMA 318(2): 132-145
Mohamed S, Johnson GR, Chen P, Hicks PB, Davis LL, Yoon J, Gleason TC, Vertrees JE, Weingart K, Tal I, Scrymgeour A, Lawrence DD, Planeta B, Thase ME, Huang GD, Zisook S, and the VAST-D Investigators., Rao SD, Pilkinton PD, Wilcox JA, Iranmanesh A, Sapra M, Jurjus G, Michalets JP, Aslam M, Beresford T, Anderson KD, Fernando R, Ramaswamy S, Kasckow J, Westermeyer J, Yoon G, D'Souza DC, Larson G, Anderson WG, Klatt M, Fareed A, Thompson SI, Carrera CJ, Williams SS, Juergens TM, Albers LJ, Nasdahl CS, Villarreal G, Winston JL, Nogues CA, Connolly KR, Tapp A, Jones KA, Khatkhate G, Marri S, Suppes T, LaMotte J, Hurley R, Mayeda AR, Niculescu AB 3rd, Fischer BA, Loreck DJ, Rosenlicht N, Lieske S, Finkel MS, Little JT

Quetiapine for the treatment of cocaine use disorder.
(2015 Apr 1)
Drug Alcohol Depend 149(): 18-24
Tapp A, Wood AE, Kennedy A, Sylvers P, Kilzieh N, Saxon AJ

The utility of the Dementia Severity Rating Scale in differentiating mild cognitive impairment and Alzheimer disease from controls.
(2015 Jul-Sep)
Alzheimer Dis Assoc Disord 29(3): 222-8
Mitchell JC, Dick MB, Wood AE, Tapp AM, Ziegler R

Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
(2011 Oct)
Clin Schizophr Relat Psychoses 5(3): 124-34
Chakos M, Patel JK, Rosenheck R, Glick ID, Hammer MB, Tapp A, Miller A, Miller D

Open trial of injectable risperidone for methamphetamine dependence.
(2009 Jun)
J Addict Med 3(2): 55-65
Meredith CW, Jaffe C, Cherrier M, Robinson JP, Malte CA, Yanasak EV, Kennedy A, Ferguson LC, Tapp AM, Saxon AJ

Show complete publication list »